SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001829126-23-006358
Filing Date
2023-09-28
Accepted
2023-09-28 16:54:38
Documents
1
Group Members
LEEN KAWASPROPEL BIO PARTNERS LLCRICHARD KAYNERICHARD KAYNE & SUZANNE KAYNE LIVING TRUST

Document Format Files

Seq Description Document Type Size
1 SC 13G/A eigerbiopharma_sc13ga.htm SC 13G/A 215385
  Complete submission text file 0001829126-23-006358.txt   217084
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Subject) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87931 | Film No.: 231290569
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1800 AVENUE OF THE STARS LOS ANGELES CA 90067-4201
Business Address 1800 AVENUE OF THE STARS LOS ANGELES CA 90067-4201 908-507-9629
Propel Bio Management, LLC (Filed by) CIK: 0001969764 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A